CD34-selected allogeneic hematopoietic stem cell transplantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD34-selected allogeneic hematopoietic stem cell transplantation, covering 2024-10-17 to 2024-10-17. Get the full timeline:
Most recent: Clinical Trial Update: CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML [Phase 2]